RIPK1 and acute lymphoblastic leukemia: Moreover, primary ALL and acute myeloid leukemia (AML) samples undergo RIPK1-dependent death upon SMAC mimetics treatment (Brumatti et al., 2016; Lalaoui et al., 2016; McComb et al., 2016; Richmond et al., 2016).